Mobile Chat Messaging for Preventing Smoking Relapse Amid the COVID-19 Pandemic: A Pilot Randomized Controlled Trial

Overview

Journal Nicotine Tob Res

Publisher Oxford University Press

Specialty Public Health

Date 2022 Feb 15

PMID 35166327

Authors

Tzu Tsun Luk

Yee Tak Derek Cheung

Helen Ching-Han Chan

Patrick Wai-Yin Fok

Kin Sang Ho

Chu Dik Sze

Tai Hing Lam

Man Ping Wang

Affiliations

Soon will be listed here.

Abstract

Introduction: The ongoing COVID-19 pandemic had reduced access to traditional, in-person smoking cessation treatment. We examined the feasibility, acceptability, and potential effectiveness of mobile chat messaging in preventing smoking relapse in smokers who have recently quit smoking.

Methods: In this assessor-blinded, pilot randomized controlled trial in five cessation clinics, we recruited adult daily smokers who had been receiving cessation treatments and abstained for 3 to 30 days. The intervention group received real-time, personalized chat messaging on relapse prevention via WhatsApp for 3 months. The control group received generic text messaging on the harms of smoking and benefits of quitting for 3 months. The primary outcome was carbon monoxide-validated abstinence at 6 months post-treatment initiation. The trial was registered with ClinicalTrials.gov (NCT04409496).

Results: From June to July 2020, 108 of 130 (83%) eligible subjects were randomized to the intervention (N = 54) or control (N = 54) groups. The retention rate was 93% at 3 months (end of treatment) and 85% at 6 months. In the intervention group, 80% of participants responded to the chat messages at least once; 43% continuously engaged with the intervention over the 3-month intervention period. By intention-to-treat, validated abstinence at 6 months was higher in the intervention than control group (31% vs. 22%), with a relative risk of 1.72 (95% CI = 0.91% to 3.23%; p = .09) after adjusting for pre-quit nicotine dependence, duration of abstinence, and cessation treatment at baseline.

Conclusions: This pilot trial showed the feasibility and acceptability of mobile chat messaging for relapse prevention with preliminary evidence on its effectiveness in increasing validated abstinence.

Implications: Smoking relapse is the most likely outcome of smoking cessation attempts and an undertreated problem. This pilot trial showed the feasibility and acceptability of personalized chat messaging via WhatsApp for relapse prevention in recent abstainers amid the COVID-19 pandemic. The higher carbon monoxide-validated abstinence rate in participants who received chat messaging than controls showed preliminary evidence on the effectiveness of the intervention. Fully powered trials are warranted to test the intervention.

Citing Articles

Mobile chat messaging for preventing relapse among people who recently quit smoking: Study protocol for a randomized controlled trial.

Su X, Wong V, Cheung Y, Chan H, Wong G, Lee J Digit Health. 2024; 10:20552076241291709.

PMID: 39439726 PMC: 11494527. DOI: 10.1177/20552076241291709.

WhatsApp-based intervention in urban Colombia to support the prevention of arboviral diseases: a feasibility study.

Carrillo M, Gessler A, Ramirez T, Cardenas Sanchez R, Lindenmeier J, Kern W Pathog Glob Health. 2024; 118(4):334-347.

PMID: 38794811 PMC: 11238608. DOI: 10.1080/20477724.2024.2358263.

Effectiveness of digital tools for smoking cessation in Asian countries: a systematic review.

Goh K, Ming L, Al-Worafi Y, Tan C, Hermansyah A, Rehman I Ann Med. 2024; 56(1):2271942.

PMID: 38346353 PMC: 11249140. DOI: 10.1080/07853890.2023.2271942.

Effect of smoking-related COVID-19 risk messaging on smoking cessation in community smokers: A pragmatic randomized controlled trial.

Weng X, Luk T, Wu Y, Zhao S, Cheung D, Tong H Tob Induc Dis. 2023; 21:77.

PMID: 37323509 PMC: 10266330. DOI: 10.18332/tid/163176.

"I didn't Notice that You Were Watching Me": Exploring a User Acceptance Study to Conduct Cultural Domain Analysis Online During the COVID-19 Pandemic.

Ackley C, Rodriguez D, Villa G Int J Qual Methods. 2023; 22:16094069231164602.

PMID: 37122441 PMC: 10116222. DOI: 10.1177/16094069231164602.

References

Michie S, Hyder N, Walia A, West R . Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav. 2011; 36(4):315-9. DOI: 10.1016/j.addbeh.2010.11.016. View

Luk T, Wong S, Lee J, Chan S, Lam T, Wang M . Exploring Community Smokers' Perspectives for Developing a Chat-Based Smoking Cessation Intervention Delivered Through Mobile Instant Messaging: Qualitative Study. JMIR Mhealth Uhealth. 2019; 7(1):e11954. PMC: 6374728. DOI: 10.2196/11954. View

Giordano V, Koch H, Godoy-Santos A, Belangero W, Pires R, Labronici P . WhatsApp Messenger as an Adjunctive Tool for Telemedicine: An Overview. Interact J Med Res. 2017; 6(2):e11. PMC: 5544893. DOI: 10.2196/ijmr.6214. View

Piper M, Bullen C, Krishnan-Sarin S, Rigotti N, Steinberg M, Streck J . Defining and Measuring Abstinence in Clinical Trials of Smoking Cessation Interventions: An Updated Review. Nicotine Tob Res. 2019; 22(7):1098-1106. PMC: 9633719. DOI: 10.1093/ntr/ntz110. View

Yu X, Xiao D, Li B, Liu Y, Wang G, Chen J . Evaluation of the Chinese versions of the Minnesota nicotine withdrawal scale and the questionnaire on smoking urges-brief. Nicotine Tob Res. 2010; 12(6):630-4. DOI: 10.1093/ntr/ntq063. View

Vangeli E, Stapleton J, Smit E, Borland R, West R . Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011; 106(12):2110-21. DOI: 10.1111/j.1360-0443.2011.03565.x. View

Cheung Y, Chan C, Lai C, Chan W, Wang M, Li H . Using WhatsApp and Facebook Online Social Groups for Smoking Relapse Prevention for Recent Quitters: A Pilot Pragmatic Cluster Randomized Controlled Trial. J Med Internet Res. 2015; 17(10):e238. PMC: 4642789. DOI: 10.2196/jmir.4829. View

Lee P . Covariate adjustments in randomized controlled trials increased study power and reduced biasedness of effect size estimation. J Clin Epidemiol. 2016; 76:137-46. DOI: 10.1016/j.jclinepi.2016.02.004. View

Leung D, Chan S, Lau C, Wong V, Lam T . An evaluation of the psychometric properties of the Smoking Self-Efficacy Questionnaire (SEQ-12) among Chinese cardiac patients who smoke. Nicotine Tob Res. 2008; 10(8):1311-8. DOI: 10.1080/14622200802238928. View

10.

Cropsey K, Trent L, Clark C, Stevens E, Lahti A, Hendricks P . How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine Tob Res. 2014; 16(10):1348-55. PMC: 4207872. DOI: 10.1093/ntr/ntu085. View

11.

Zeng E, Heffner J, Copeland W, Mull K, Bricker J . Get with the program: Adherence to a smartphone app for smoking cessation. Addict Behav. 2016; 63:120-4. PMC: 5501958. DOI: 10.1016/j.addbeh.2016.07.007. View

12.

Patwardhan P . COVID-19: Risk of increase in smoking rates among England's 6 million smokers and relapse among England's 11 million ex-smokers. BJGP Open. 2020; 4(2). PMC: 7330228. DOI: 10.3399/bjgpopen20X101067. View

13.

Cahill K, Stevens S, Perera R, Lancaster T . Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013; (5):CD009329. PMC: 8406789. DOI: 10.1002/14651858.CD009329.pub2. View

14.

Luk T, Zhao S, Weng X, Wong J, Wu Y, Ho S . Exposure to health misinformation about COVID-19 and increased tobacco and alcohol use: a population-based survey in Hong Kong. Tob Control. 2020; 30(6):696-699. DOI: 10.1136/tobaccocontrol-2020-055960. View

15.

Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios L . A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010; 10:1. PMC: 2824145. DOI: 10.1186/1471-2288-10-1. View

16.

Livingstone-Banks J, Norris E, Hartmann-Boyce J, West R, Jarvis M, Chubb E . Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. 2019; 2019(10). PMC: 6816175. DOI: 10.1002/14651858.CD003999.pub6. View

17.

Li Y, Luk T, Wu Y, Cheung D, Li W, Tong H . High Perceived Susceptibility to and Severity of COVID-19 in Smokers Are Associated with Quitting-Related Behaviors. Int J Environ Res Public Health. 2021; 18(20). PMC: 8535969. DOI: 10.3390/ijerph182010894. View

18.

Eldridge S, Chan C, Campbell M, Bond C, Hopewell S, Thabane L . CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016; 355:i5239. PMC: 5076380. DOI: 10.1136/bmj.i5239. View

19.

Grummon A, Hall M, Mitchell C, Pulido M, Sheldon J, Noar S . Reactions to messages about smoking, vaping and COVID-19: two national experiments. Tob Control. 2020; 31(3):402-410. PMC: 7669534. DOI: 10.1136/tobaccocontrol-2020-055956. View

20.

Cha S, Ganz O, Cohn A, Ehlke S, Graham A . Feasibility of biochemical verification in a web-based smoking cessation study. Addict Behav. 2017; 73:204-208. PMC: 5542679. DOI: 10.1016/j.addbeh.2017.05.020. View